IRVSX
Price
$30.96
Change
-$0.73 (-2.30%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

IRVSX vs RMFCX

Header iconIRVSX vs RMFCX Comparison
Open Charts IRVSX vs RMFCXBanner chart's image
Voya Russell Large Cap Value Idx Port S
Price$30.96
Change-$0.73 (-2.30%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
IRVSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IRVSX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRVSX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. IRVSX (214M). RMFCX (1.69) and IRVSX (1.62) have matching dividends . IRVSX was incepted earlier than RMFCX: IRVSX (16 years) vs RMFCX (23 years). IRVSX is a more actively managed with annual turnover of: 33.00 vs. RMFCX (25.00). IRVSX has a lower initial minimum investment than RMFCX: IRVSX (0) vs RMFCX (250). IRVSX annual gain was more profitable for investors over the last year : 15.74 vs. RMFCX (12.63). IRVSX return over 5 years is better than : 43.34 vs. RMFCX (40.39).
IRVSXRMFCXIRVSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD14.55111.423127%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets214M98.7B0%
Annual Yield % from dividends1.621.6996%
Returns for 1 year15.7412.63125%
Returns for 3 years21.7814.16154%
Returns for 5 years43.3440.39107%
Returns for 10 years87.6761.84142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc